![Hengrui therapeutics, inc.](/api/images/company-pic/0-717888-company.png)
Contact us
About company
HTI is a U.S. biopharmaceutical company dedicated to developing and commercializing innovative drugs to address unmet medical needs. HTI’s current therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss in the pipeline.
US
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews